🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This clinical trial will utilize a neoantigen nanovaccine constructed from ...
Status
Recruiting
Location
Nanjing Drum Tower Hospital Affiliated to Medical School of Nanjing University
Start Date
2026-03-23
Trial ID
NCT07353645
Treatments Being Tested
This is a single institution, Phase 1 study for patients with Stage III/IV ...
Status
Recruiting
Location
Johns Hopkins University
Start Date
2022-11-01
Trial ID
NCT05254184
Treatments Being Tested
This study will determine the safety and tolerability and establish a preli...
Status
Terminated
Location
Banner MD Anderson Cancer Center ( Site 1008)
Start Date
2019-06-26
Trial ID
NCT03948763
Treatments Being Tested
The goal of this clinical trial is to test the safety and tolerability of a...
Status
Active Not Recruiting
Location
Georgetown Lombardi Comprehensive Cancer Center
Start Date
2024-01-31
Trial ID
NCT06015724
Treatments Being Tested
This is a pilot clinical trial for subjects with local advanced/metastatic ...
Status
Active Not Recruiting
Location
Biotherapeutic Department of Chinsese PLA Gereral Hospital
Start Date
2023-04-03
Trial ID
NCT05631899
Treatments Being Tested
The goal of this study is to evaluate the safety and efficacy of mRNA vacci...
Status
Recruiting
Location
West China Hospital, Sichuan University
Start Date
2025-06-05
Trial ID
NCT07004244
Treatments Being Tested
The purpose of this study is to determine the optimal dose of AGEN2373 that...
Status
Recruiting
Location
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Start Date
2025-05-27
Trial ID
NCT06782932
Treatments Being Tested
The purpose of this study is to evaluate the safety, immunogenicity and pre...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-01-20
Trial ID
NCT07396090
Treatments Being Tested
This phase II trial tests how well giving CIMAvax-EGF with KRAS G12C inhibi...
Status
Not Yet Recruiting
Location
Roswell Park Cancer Institute
Start Date
2026-09-01
Trial ID
NCT07543172
Phase 1b study evaluating the efficacy and immune response to a synthetic l...
Status
Recruiting
Location
Sidney Kimmel Comprehensive Cancer Center
Start Date
2024-11-04
Trial ID
NCT06411691
Treatments Being Tested